Yoshikane Kikushige

10PUBLICATIONS
26CO-AUTHORS
Molecular targetsGene and molecular therapyPsycholinguistics (incl. speech production and comprehension)Predictive and prognostic markersInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 05, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.

Gentaro Kawano, Riichiro Ikeda, Daisuke Ishihara

|May 22, 2025
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML.

Jian Zou, Haruka Kinosada, Shin-Ichiro Takayanagi

|Apr 28, 2025
Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring.

Hidetaka Nakagaki, Takuji Yamauchi, Takahiko Mukaino

|Mar 11, 2025
Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy.

Tomoko Nomiyama, Daiki Setoyama, Ikumi Yamanaka

|Feb 20, 2025
Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RARĪ±.

Mariko Minami, Teppei Sakoda, Gentaro Kawano

|Dec 27, 2024
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.

Teppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune

Pageof 2

Frequent Collaborators

3 joint publications

Koichi Akashi

2 joint publications

Yuya Kunisaki

2 joint publications

Kensuke Sasaki

1 joint publications

Koji Nagafuji